Merck (MRK)
$92.15
0.10 (0.11%)
MRK Stock Quote Delayed 30 Minutes
The Best Play in Biotechs: M&A
Investors in biotech stocks have much to look forward to as Big Pharma increasingly looks to shore up its pipelines via M&A.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
$90.58
Market Cap
233.03B
PE Ratio
13.68
EPS
6.7363
Volume (Avg. Vol.)
14.13M
Day's Range
$90.71 - $92.35
52-Week Range
$81.04 - $132.70
Dividend & Yield
$3.12 (3.39%)
MRK Stock Predictions, Articles, and Merck News
45 Blue-Chip Dividend Stocks That Increased Payouts in Q4 2014
Dividend stocks in just about every sector thrilled investors with meaningful payout raises in Q4. Here's a look at 45 of the biggest blue chips to up the ante.
5 Stocks With Bad Analyst Earnings Revisions — CQP ATE WTSL IMI AVNW
This week, these five stocks have the worst ratings in Analyst Earnings Revisions, one of the eight Fundamental Categories on Portfolio Grader.
Biggest Movers in Healthcare Stocks Now – ACHN EXAS CBPO ABMD
Healthcare stocks fell on Wall Street on Monday morning, down 0.7%.
5 Stocks With Bad Analyst Earnings Revisions — CQP ATE WTSL IMI AVNW
This week, these five stocks have the worst ratings in Analyst Earnings Revisions, one of the eight Fundamental Categories on Portfolio Grader.
Biggest Movers in Healthcare Stocks Now – GSK SEM HSIC SPNC
Healthcare stocks finished down broadly on Wall Street on Tuesday, with the sector seeing an overall decline of 1.2%.
Hottest Healthcare Stocks Now – PTCT BSX NXTM BIIB
Healthcare stocks finished down 1.5% on Wall Street today.
5 Stocks With Bad Analyst Earnings Revisions — CQP ATE WTSL IMI AVNW
This week, these five stocks have the worst ratings in Analyst Earnings Revisions, one of the eight Fundamental Categories on Portfolio Grader.
Hottest Healthcare Stocks Now – ZLTQ PBYI CLVS ACHC
Healthcare stocks rose 0.3% on Wall Street on Thursday.
Hottest Healthcare Stocks Now – BLUE SGEN BABY ISIS
More broadly, the Dow Jones Industrial Average fell 0.8%, the Nasdaq declined 0.6% and the S&P 500 was down 0.8%.
Biggest Movers in Healthcare Stocks Now – BLUE ISIS MACK STE
More broadly, the Dow Jones Industrial Average declined 0.8%, the Nasdaq fell 0.6% and the S&P 500 was down 0.8%.
Why Louisiana-Pacific, Best Buy, and Cubist Pharmaceuticals are 3 of Today’s Best Stocks
All three indices sank today on crude oil and Asian weakness, but Louisiana Pacific (LPX), Best Buy (BBY), and Cubist Pharmaceuticals (CBST) bucked the trend to finish significantly higher.
Biggest Movers in Healthcare Stocks Now – CBST ALNY ISIS BLUE
Healthcare stocks rose 0.6% on Wall Street so far on Monday.
Mickey Mouse, Shoes, Spam Top 13 Dividend Stocks Increasing Payouts
Over the past fortnight, there was a baker’s dozen of high-profile companies increasing dividends, including an entertainment icon, an athletic wear giant and a food company best known for making Spam.
Merck (MRK) Sends Cubist Pharmaceuticals Inc (CBST) Stock Soaring on $9.5 Billion Offer
The healthcare M&A craze of 2014 continues as Merck snaps up Cubist Pharmaceuticals, which has promising drugs in the pipeline and a niche focus.
Hottest Healthcare Stocks Now – EXAS THC ACHN LCI
More broadly, the Dow Jones Industrial Average rose 0.2%, the Nasdaq increased 0.2% and the S&P 500 climbed 0.2%.
5 Stocks With Awful Analyst Earnings Revisions — CQP WYY ATE WTSL IMI
This week, these five stocks have the worst ratings in Analyst Earnings Revisions, one of the eight Fundamental Categories on Portfolio Grader.
5 Stocks With Crummy Analyst Earnings Revisions — CQP WYY ATE WTSL IMI
This week, these five stocks have the worst ratings in Analyst Earnings Revisions, one of the eight Fundamental Categories on Portfolio Grader.
5 Stocks With Crummy Analyst Earnings Revisions — CQP WYY ATE WTSL IMI
This week, these five stocks have the worst ratings in Analyst Earnings Revisions, one of the eight Fundamental Categories on Portfolio Grader.
